This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Commentary

Diagnosing and Managing Complicated ADHD

Robert L. Findling, MD (Chair); L. Eugene Arnold, MD, MEd; Laurence L. Greenhill, MD; Christopher J. Kratochvil, MD; and James J. McGough, MD

Published: December 14, 2007

This CME activity is expired. For more CME activities, visit CMEInstitute.com.
Find more articles on this and other psychiatry and CNS topics:
The Journal of Clinical Psychiatry
The Primary Care Companion for CNS Disorders



Article Abstract


Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Dr. Findling: The purpose for this roundtable on the diagnosis and management of complicated attention-deficit/hyperactivity disorder (ADHD) is to help clinicians distinguish ADHD from comorbid psychiatric disorders and to compare strategies, both pharmacologic and nonpharmacologic, for managing complicated ADHD.

Factors That Complicate ADHD

Dr. Findling: What are the key factors that complicate ADHD?’


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 68

Quick Links: ADHD , Neurodevelopmental

References

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...

Read More...